ArticleOne health (Amsterdam, Netherlands)2026
Genomic insights into carbapenemase- and extended-spectrum β-lactamase-producing gram-negative bacteria in aquatic and terrestrial animal reservoirs in the United Arab Emirates.
Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global spread of carbapenemase- and extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria represents a major One Health challenge, driven by interconnected human, animal, and environmental reservoirs. However, genomic data on antimicrobial-resistant bacteria associated with aquatic and terrestrial animals in the United Arab Emirates (UAE) remain scarce, limiting assessment of their potential role in resistance dissemination. This study investigated the phenotypic and genomic characteristics of resistant Gram-negative bacteria recovered from these animal reservoirs. Methods: Sixty aquarium-associated samples were collected, yielding 69 Gram-negative isolates. Antimicrobial susceptibility testing, phenotypic detection of ESBL and carbapenemase activity, molecular screening of resistance genes, and whole-genome sequencing of selected isolates were performed. Phylogenetic analyses were conducted to assess evolutionary relatedness with global strains. Results: The isolates were mainly identified as Conclusion: Aquatic and terrestrial animals in the UAE serve as important reservoirs for clinically relevant antimicrobial resistance. These findings underscore the need for integrated One Health genomic surveillance to mitigate the transboundary spread of high-risk resistant lineages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.